Navigation Links
Chantix And NuvaRing Lawsuit Funding Added To Pharmaceutical Drug List At Legal-Bay
Date:6/13/2013

SAN FRANCISCO, June 13, 2013 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today that they are one of the first funding firms to offer plaintiffs of both Chantix and NuvaRing litigation's with lawsuit pre-settlement funding.  Legal-Bay is a leader in both product liability funding in case of recalled hip products and transvaginal mesh cases, as well as bad pharmaceutical drugs.  The addition to begin funding Chantix and NuvaRing indicates the company's intentions to be at the forefront of funding in mass tort cases. 

(Logo: http://photos.prnewswire.com/prnh/20130613/PH30672LOGO)

"We believe both the Chantix and NuvaRing litigation represent mass tort plaintiffs with serious side effects to the drugs and product taken.  Although most companies in the legal funding community believe these litigations still pose significant risk, we remain steadfast in our commitment to assist victims of Chantix and NuvaRing who need cash to pay for bills and live until their settlement is obtained", Said Chris Janish, CEO of Legal-Bay.  Legal-Bay's NuvaRing and Chantix funding products are not lawsuit loans, as there are no monthly payments and the funds only need to be paid back if you win your case.    

Chantix the smoking cessation drug has left many people with serious bouts of depression and ultimately suicidal actions in some cases.  NuvaRing was billed as an innovative birth control option for women, however the side effects to the product included heart attack, stroke, pulmonary embolisms and vein issues. 

Chantix and NuvaRing is in addition to the following bad pharmaceutical drugs that Legal-Bay is actively funding:

  • Accutane
  • Actos
  • Avandia
  • Gadolinum
  • Prempro/HRT
  • Vioxx
  • Yaz, Yasmin, and Ocella

Legal-Bay's "Big Pharma" funding list is constantly changing, so feel free to inquire about funding on a product that you do not see above. 

If you were injured by a Chantix, NuvaRing or another pharmaceutical drug and need a lawsuit cash advance, feel free to apply online at: http://lawsuitssettlementfunding.com or by calling Legal-Bay toll free at 877.571.0405 where live agents are always available to answer your Chantix or NuvaRing Lawsuit Funding questions.  (You must have a lawyer to apply for Chantix lawsuit funding, however if you need a Chantix lawyer or NuvaRing lawyer, feel free to contact Legal-Bay and they can provide you with an attorney who will give you a free legal consultation.)

Contact:  Patty Kirby, Head of Client Relations
              Ph. 877.571.0405   Email:  Info@legal-bay.com


'/>"/>
SOURCE Legal-Bay LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. RD Legal Offers Funding to Plaintiffs Attorneys with Chantix Settlements
2. Royalty Pharma Statement Regarding Withdrawal of Elan Lawsuit
3. SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in AMAG Pharmaceuticals, Inc. of Class Action Lawsuit Investigation - AMAG
4. Stryker And DePuy Pinnacle Hip Lawsuit Settlement News Update
5. The Law Offices of Marc S. Henzel Announces Class Action Lawsuit Against Aveo Pharmaceuticals, Inc. and Certain Officers -- (Nasdaq: AVEO) was filed on behalf of stockholders
6. Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
7. Medstrat Posts Documents Confirming Terms Of Dismissal Of Merges Lawsuit
8. Vaginal Mesh Lawsuit Website Launched by Dr. Greg Vigna
9. Medifast, Inc. Announces Favorable Resolution of Securities Class Action Lawsuit
10. Star Scientific Responds to Plaintiffs Purported Class Action Lawsuit
11. OrbusNeich File Patent Infringement Lawsuit Against Boston Scientific in Ireland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
Breaking Medicine News(10 mins):